Latest news from the European Committee for Treatment and Research in Multiple Sclerosis 2019
On September 11-13, 2019, the European Committee for Treatment and Research in Multiple Sclerosis (a conference known as ECTRIMS) held their 35th Congress…
Update: International Progressive MS Alliance Collaborative Networks
The International Progressive MS Alliance is an unprecedented global collaboration of multiple sclerosis (MS) organizations, healthcare professionals, the pharmaceutical industry companies, trusts, foundations,…
Faces Behind the Science: Asanga Weliwitigoda
Name: Asanga Weliwitigoda Affiliation: Benaroya Research Institute at Virginia Mason Stage of research: Postdoctoral fellowship Focus on: Mechanisms of disease How I’m involved…
Faces Behind the Science: Marc-André Lécuyer
Name: Marc-André Lécuyer Affiliation: University of Gottingen Stage of research: Postdoctoral fellowship Focus on: Mechanisms of disease How I’m involved with MS research:…
ACTRIMS Forum 2019 and its focus on precision Medicine in MS
The theme of the #ACTRIMS Forum 2019 was “Precision Medicine Approaches for MS: Scientific Principles to Clinical Application.” Many talks and presentations were…
Behind the research: meet the CanProCo team
The Canadian Proactive Cohort Study for People Living with MS (CanProCo) is a revolutionary project in every sense of the word. Scope. Scale.…
Cutting Edge Developments: Treatment in development, technology-based clinical measures, and predicting progression in MS
Presenters at the cutting-edge developments in MS session at #ACTRIMS deliver the latest key findings on pivotal studies. At the session, we heard…
Emerging Concepts in MS: MRI measure as an indicator of potential conversion to SPMS, novel therapeutic targets of neuroinflammation, and roles of biological measures of aging in MS
Presenters at the emerging concepts in MS session at the ACTRIMS 2019 Forum deliver results on novel research areas in MS. At the…